Susana Rives

19PUBLICATIONS
132CO-AUTHORS
Child and adolescent developmentHaematological tumoursOther European languagesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 29, 2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

|Apr 04, 2026
Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy.

Anna Alonso-Saladrigues, Elena Esperanza-Cebollada, Clara Vicente-Garcés

|Mar 24, 2026
Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups.

Cristina Rivera-Pérez, Mireia Morgades, Anna Alonso-Saladrigues

|Feb 17, 2026
Cross-border access to clinical trials: participation of pediatric patients and language inclusion.

Begonya Nafria, Joana Claverol, Marta Cubells

|Oct 14, 2025
Point-of-care CAR T-cell therapy: toward broader access.

Susana Rives

|Jun 24, 2025
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL.

Rakesh Awasthi, Stephan A Grupp, Edward R Waldron

Pageof 4

Frequent Collaborators

6 joint publications

Andre Baruchel

4 joint publications

Theodore W Laetsch

4 joint publications

Jochen Buechner

4 joint publications

Barbara De Moerloose